LTR Pharma (ASX:LTP) Retained Earnings : A$-3.86 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. LTR Pharma's retained earnings for the quarter that ended in Jun. 2023 was A$-3.86 Mil.

LTR Pharma's quarterly retained earnings declined from Jun. 2021 (A$-0.04 Mil) to Jun. 2022 (A$-1.07 Mil) and declined from Jun. 2022 (A$-1.07 Mil) to Jun. 2023 (A$-3.86 Mil).

LTR Pharma's annual retained earnings declined from Jun. 2021 (A$-0.04 Mil) to Jun. 2022 (A$-1.07 Mil) and declined from Jun. 2022 (A$-1.07 Mil) to Jun. 2023 (A$-3.86 Mil).

LTR Pharma Retained Earnings Historical Data

The historical data trend for LTR Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Retained Earnings Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Retained Earnings

-0.04

-1.07

-3.86

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Retained Earnings	-0.04	-1.07	-3.86

LTR Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

LTR Pharma (ASX:LTP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines